Countdown to Webinar: 10 Sino-British Industry Leaders to Discuss Sustainable Future of Life Sciences Enterprises
In 2020, the novel coronavirus swept across the globe like a prairie fire. Its profound impact on various industries spread rapidly, akin to falling dominoes. Even life sciences companies, which appeared to be fortunately positioned at the “eye of the storm,” did not necessarily enjoy smooth sailing.
In the face of the global pandemic of COVID-19, a series of unstoppable chain reactions have made us more profoundly aware that:Today, humanity is a community living within an ecosystem characterized by deep industrial integration and heightened globalization.
The predicament brought about by the pandemic,Laying bare the immense demand for healthcare and medical services among the general public,has also brought to the life sciences industryUnprecedented Opportunities.
Focus on the Life Sciences Sector: An Online Seminar with 10 Leading Industry and Economic Experts from China and the UK
Limited to 300 attendees
To this end, byAstraZenecaandWuxi CityCo-createdWuxi International Life Science Innovation Park (I·Campus),Join ForcesUK BioIndustry Association (BIA)Co-hosting the webinar “Sharing Anti-Epidemic Experience, Pioneering a Sustainable Future,” which invites leading figures from government, business, the ecosystem, and capital sectors to discuss the pandemic’s impact on industries, corporate response strategies, and new opportunities in China in the post-pandemic era. Participation from all sectors is warmly welcomed.
Registration Method: Please submit by 12:00 PM on April 2, 2020Click the linkorScan the QR code below, complete the attendance application. Upon approval, we will send the Zoom live streaming link to your registered email address or mobile phone number.
The conference is limited to 300 attendees; please apply promptly:
http://vcbeat100.mikecrm.com/1kxi59y
Wuxi International Life Science Innovation Park
Wuxi International Life Science Innovation Park (I·Campus) is a global innovation incubation platform jointly established by the Wuxi Municipal Government, the Wuxi New District Government, and AstraZeneca. Guided by the vision of “Pooling Global Wisdom to Support Healthy China,” the Innovation Park integrates key elements of the 4D industries—pharmaceuticals, medical devices, diagnostics, and digitalization. By collaborating with diverse stakeholders from government, industry, research, academia, healthcare, and investment sectors both domestically and internationally, it is committed to building a life science incubation and innovation platform that covers the entire lifecycle, thereby fostering an open, collaborative, patient-centric innovation ecosystem.
UK BioIndustry Association
The BioIndustry Association (BIA) is the UK’s trade association for innovative life sciences. Its goal is to secure the UK’s position as a global hub and premier destination for innovative research and commercialization, enabling its world-leading research base to deliver healthcare solutions that truly transform people’s lives. In 2019, the BioIndustry Association established a strategic partnership with the Wuxi International Life Sciences Innovation Park.
AstraZeneca
AstraZeneca is a science-led global biopharmaceutical company dedicated to the research, development, manufacturing, and marketing of prescription medicines, with a primary focus on three major therapeutic areas: oncology, cardiovascular, renal and metabolism, and respiratory diseases. With operations in more than 100 countries, AstraZeneca’s innovative medicines benefit millions of patients worldwide. For more information, please visit www.astrazeneca.com.